Skip to content

MBX Biosciences, Inc. MBX Return on invested capital

Return on invested capital at other companies

Eli Lilly logo
Eli LillyLLY
42%+16.6pp
Amgen logo
AmgenAMGN
14.1%+4.0pp
Viking Therapeutics logo
Viking TherapeuticsVKTX
-59.2%-292pp
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
-165.3%+14.1pp
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
-70.2%-7.5pp
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
-45.1%+1.9pp

Other financials

Income statement

See full
Operating income-$27.3M-2.8%
Net income-$23.5M+1.5%
EPS (diluted)-$0.50+29.6%

Balance sheet

See full
Cash & equivalents$45.2M+51.2%
Total debt$555.0K+327%
Total equity$437.8M+85.9%
Total assets$452.7M+84.1%

Cash flow

See full
Operating cash flow-$20.2M+10.9%
CapEx$437.0K+1,357%
Free cash flow-$20.6M+9.1%

Valuation

See full
Market cap$2.21B+475%
Enterprise value$2.16B+533%

Returns & leverage

See full
Return on equity-25.7%
Debt / equity0.0×
Current ratio30.8×+7.5×

Where this comes from

Calculated from MBX Biosciences, Inc.’s reported figures.

Based on trailing twelve months.

The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about MBX Biosciences, Inc.'s return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MBX Biosciences, Inc.'s return on invested capital?
MBX Biosciences, Inc. (MBX) reported return on invested capital of -33% in Q1 2026.
What does return on invested capital mean?
Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.